@article{vokinger_prices_2020,
	title = {Prices and clinical benefit of cancer drugs in the {USA} and {Europe}: a cost-benefit analysis},
	volume = {21},
	issn = {1474-5488},
	shorttitle = {Prices and clinical benefit of cancer drugs in the {USA} and {Europe}},
	doi = {10.1016/S1470-2045(20)30139-X},
	language = {eng},
	number = {5},
	journal = {The Lancet. Oncology},
	author = {Vokinger, Kerstin N. and Hwang, Thomas J. and Grischott, Thomas and Reichert, Sophie and Tibau, Ariadna and Rosemann, Thomas and Kesselheim, Aaron S.},
	year = {2020},
	pmid = {32359489},
	keywords = {Antineoplastic Agents, Cost-Benefit Analysis, Drug Costs, England, Europe, France, Germany, Humans, Medical Oncology, Neoplasms, United States},
	pages = {664--670}
}